Paloma Partners’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-79,200
| Closed | -$87.1K | – | 834 |
|
|
2024
Q2 | $87.1K | Buy |
+79,200
| New | +$87.1K | ﹤0.01% | 674 |
|
|
2020
Q3 | – | Sell |
-71,800
| Closed | -$116K | – | 1828 |
|
|
2020
Q2 | $116K | Buy |
+71,800
| New | +$116K | ﹤0.01% | 1687 |
|
|
2020
Q1 | – | Sell |
-14,650
| Closed | -$28K | – | 1071 |
|
|
2019
Q4 | $28K | Buy |
+14,650
| New | +$28K | ﹤0.01% | 1790 |
|
|
2019
Q3 | – | Sell |
-20,500
| Closed | -$45K | – | 1567 |
|
|
2019
Q2 | $45K | Sell |
20,500
-400
| -2% | -$878 | ﹤0.01% | 1410 |
|
|
2019
Q1 | $125K | Buy |
+20,900
| New | +$125K | ﹤0.01% | 1241 |
|